Another Look at Fungus for Infection

June 13th, 2007 by Rhoda

The University of Strathclyde’s Institute for Drug Research, or the SIDR, is bringing together scientists to focus on the discovery of natural products that could lead to new medical products. Their hope is to find new drugs to fight diseases such as cancer and resistant infections like MRSA. CABI, a leading bioservices organization, has one of the largest genetic collections of fungi, over 28,000 strains, which the SIDR will be screening to identify compounds that could be potentially developed into drugs that will combat many diseases. There are already drugs derived from fungi such ad penicillin and this huge collection of fungi gives hope to many, many, more for the future. Fungal antibiotics stimulate the production of human antibiotics which will kill bacterial and viral infections. I expect we will be hearing more about fungal and Phage Therapies as the search for a cure continues with good results coming from both, perhaps used in conjunction.

Posted in IN the News

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

About Rhoda’s MRSA Story

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aliquam justo tortor, dignissim non, ullamcorper at, lobortis vitae, risus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aliquam erat volutpat. Aenean mi pede, dignissim in, gravida varius, fringilla ullamcorper, augue.

(edit footer.php to change this text)